India to offer incentives for manufacturers looking to shift out of China

NEW DELHI: The Prime Minister’s Office, Niti Aayog and the Department for Promotion of Industry and Internal Trade are framing up a plan to offer incentives to attract companies looking to shift manufacturing activities out of China. India has set up panels to directly interact with firms that may want to shift out of China.

The benefits will be on the lines of those given to manufacture of electronic and medical devices. These may include production-linked incentives such as capital expenditure benefits. There is a growing realisation among multinational firms after the Covid-19 pandemic that capacities cannot be concentrated at one place.

“More sectors could be offered sops on the lines of electronics and medical devices… Those are being worked out. Last year’s corporate tax rate cut and these additional sops would make India with its large market as competitive as Vietnam.”

“A number of countries are now keen that their industry diversifies manufacturing. There is going to be a shift,” the official further added, that India has changed its policies considerably to emerge as an attractive alternative destination.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Maha cops bust three factories, seize drugs worth Rs 56 crore in Bengaluru

    Maha cops bust three factories, seize drugs worth Rs 56 crore in Bengaluru

    ‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

    ‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

    Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

    Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

    National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

    National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

    Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

    Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

    Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

    Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US